AbbVie (ABBV) has moved in a wide range so far today. Let's check out the charts and indicators to see if this could be an inflection point.
More from Investing
Here's how I'm making out on these names that were down at the end of last year.
The crowd of investors is often irrational, but most of the time it's right.
New to this exclusive club, these names have proven effective long-term compounders of shareholder wealth and dividend income.
We had the Fed's rate decision, jobs numbers, and mega-cap tech earnings land. But here's what was the wildest action.